HemaSphere (Jun 2022)

P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY.

  • F. Khadadah,
  • A. G. Turkina,
  • E. Lomaia,
  • E. V. Morozova,
  • O. A. Shukhov,
  • A. Petrova,
  • T. Chitanava,
  • J. J. Vlasova,
  • E. Kuzmina,
  • I. Nemchenko,
  • E. Y. Chelysheva,
  • A. Bykova,
  • M. Gurianova,
  • A. Xenocostas,
  • L. Busque,
  • K. Jamani,
  • S. Cerquozzi,
  • P. Kuruvilla,
  • R. Kaedbey,
  • B. Leber,
  • S. Assouline,
  • D. D. H. Kim

DOI
https://doi.org/10.1097/01.HS9.0000845716.75856.2d
Journal volume & issue
Vol. 6
pp. 603 – 604

Abstract

Read online

No abstracts available.